|
1/2025
vol. 17
Original paper
Diaphragm and lung dose in liver high-dose-rate interstitial brachytherapy: A dosimetry and toxicity report
Keerthaanaa Yogabalan
1, 2
,
Gokula Kumar Appalanaido
1, 2
,
Nursyatina Abdul Raof
2
,
Ahamed Badusha Mohamed Yoosuf
5, 6
,
Mohd Zahri Abdul Aziz
1, 2
- Advanced Management of Liver Malignancies Program, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia
- Radiotherapy Unit, Pusat Perubatan Universiti Sains Malaysia Bertam, Penang, Malaysia
- Clinical Diagnostic Lab, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia
- Medical Radiation Programme, School of Health Science, Universiti Sains Malaysia, Kelantan, Malaysia
- Oncology, King Adullah International Medical Research Center, Riyadh, Saudi Arabi
- Oncology/Radiation Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia
- Advanced Medical and Dental Institute Universiti Sains Malaysia, Penang, Malaysia
- School of Medical Science, Universiti Sains Malaysia, Kelantan, Malaysia
J Contemp Brachytherapy 2025; 17, 1: 28–32
Online publish date: 2025/02/28
Get citation
1. Raihan R, Azzeri AH, Shabaruddin F et al. Hepatocellular carcinoma in malaysia and its changing trend. Euroasian J Hepatogastroenterol 2018; 8: 54-56. 2.
Karagiannis E, Strouthos I, Leczynski A et al. Narrative review of high-dose-rate interstitial brachytherapy in primary or secondary liver tumors. Front Oncol 2022; 12: 800920. 3.
Walter F, Nierer L, Rottler M et al. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma. Radiat Oncol 2021; 16: 86. 4.
Hass P, Steffen I, Powerski M et al. First report on extended distance between tumor lesion and adjacent organs at risk using interventionally applied balloon catheters: a simple procedure to optimize clinical target volume covering effective isodose in interstitial high dose-rate brachytherapy of liver malignomas. J Contemp Brachytherapy 2019; 11: 152-161. 5.
Lee SU, Yoon SM, Cheng JC-H et al. Multi-institutional retrospective study of radiotherapy for hepatocellular carcinoma in the caudate lobe. Front Oncol 2021; 11: 646473. 6.
Butterworth KT, Prise KM, Hounsell AR et al. An overview of current practice in external beam radiation oncology with consideration to potential benefits and challenges for nanotechnology – cancer nanotechnology. Cancer Nanotechnol 2017; 8: 3. 7.
Bilski M, Korab K, Stąpór-Fudzińska M et al. HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases – A dosimetric comparison study of three radioablative techniques. Clin Transl Radiat Oncol 2024; 48: 100815. 8.
Bilski M, Peszyńska-Piorun M, Konat-Bąska K et al. Radiotherapy as a metastasis directed therapy for liver oligometastases – comparative analysis between CT-guided interstitial HDR brachytherapy and two SBRT modalities performed on double-layer and single layer LINACs. Front Oncol 2024; 14: 1478872. 9.
Bretschneider T, Ricke J, Gebauer B et al. Image-guided high-dose-rate brachytherapy of malignancies in various inner organs – technique, indications, and perspectives. J Contemp Brachytherapy 2016; 3: 251-261. 10.
Michel R, Françoise I, Laure P et al. Dose to organ at risk and dose prescription in liver SBRT. Rep Pract Oncol Radiother 2017; 22: 96-102. 11.
Sioshansi S, Rava PS, Karam AR et al. Tolerance dose of the diaphragm with liver SBRT. Int J Radiat Oncol Biol Phys 2014; 90. 12.
Appalanaido GK, Ahmad MZ, Shukor SA et al. Pathological complete response with immunotherapy and brachytherapy to 15 metastatic liver lesions in a single patient. Hepat Oncol 2022; 9: HEP44. 13.
Timmerman R. A story of hypofractionation and the table on the wall. Int J Radiat Oncol Biol Phys 2022; 112: 4-21. 14.
Sioshansi S, Dunlap NE, Stephans KL. Diaphragm injury after liver stereotactic body radiation therapy. Pract Radiat Oncol 2014; 4: e227-30. 15.
Scheenstra AEH, Rossi MMG, Belderbos JSA et al. Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy. Int J Radiat Oncol Biol Phys 2014; 88: 224-228. 16.
Hsieh CH, Lin YC, Chen YJ et al. Diaphragm contractile dysfunction causes by off-target low-dose irradiation. 17.
Am J Transl Res 2016; 8: 1510-1517. 18.
Voyant C, Julian D, Roustit R et al. Biological effects and equivalent doses in radiotherapy: A software solution. Rep Pract Oncol Radiother 2014; 19: 47-55. 19.
Duque AS, Corradini S, Kamp F et al. The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy. Radiat Oncol 2020; 15: 60. 20.
Thrower SL, Shaitelman SF, Bloom E et al. Comparison of dose distributions with TG-43 and collapsed cone convolution algorithms applied to accelerated partial breast irradiation patient plans. Int J Radiat Oncol Biol Phys 2016; 95: 1520-1526.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License ( http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
|
